Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Active, not recruiting · NCT03604198 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome | ACTH-dependent Cushing syndrome, Cushing syndrome, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, adenocarcinoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, brain disorder, carcinoma, cardiovascular disorder, central nervous system disorder, diabetes mellitus, ectopic ACTH secretion syndrome, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hyperpituitarism, hypertensive disorder, hypothalamic disorder, malignant endocrine neoplasm, metabolic disease, neoplasm, nervous system disorder, paraneoplastic syndrome, pituitary gland disorder, type 2 diabetes mellitus, vascular disorder | Active, not recruiting | Phase 2 | 2026-10-09 | NCT03604198 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Corcept Therapeutics | 9 |
48 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Site 1 | Indianapolis | United States | 1 |
| Site 10 | Atlanta | United States | 1 |
| Site 11 | Dallas | United States | 1 |
| Site 12 | Houston | United States | 1 |
| Site 13 | Fall River | United States | 1 |
| Site 14 | Vienna | Austria | 1 |
| Site 16 | Munich | Germany | 1 |
| Site 17 | Madrid | Spain | 1 |
| Site 18 | Girona | Spain | 1 |
| Site 19 | Seville | Spain | 1 |
| Site 2 | Pittsburgh | United States | 1 |
| Site 20 | Ramat Gan | Israel | 1 |
| Site 21 | Naples | Italy | 1 |
| Site 24 | New York | United States | 1 |
| Site 25 | Milan | Italy | 1 |
| Site 27 | Baltimore | United States | 1 |
| Site 28 | Bucharest | Romania | 1 |
| Site 29 | Tel Aviv | Israel | 1 |
| Site 3 | St Louis | United States | 1 |
| Site 31 | Bucharest | Romania | 1 |
| Site 32 | Fort Worth | United States | 1 |
| Site 33 | Rotterdam | Netherlands | 1 |
| Site 34 | Jackson | United States | 1 |
| Site 35 | Stanford | United States | 1 |
| Site 36 | Rochester | United States | 1 |